tyrosine has been researched along with Long QT Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bohannon, BM; Corradi, V; Jowais, JJ; Larsson, HP; Liin, SI; Nyberg, L; Olivier-Meo, V; Tieleman, DP | 1 |
Hong, HK; Jo, SH; Lee, BH; Park, MH | 1 |
Kim, EJ; Kim, KS; Park, SJ | 1 |
3 other study(ies) available for tyrosine and Long QT Syndrome
Article | Year |
---|---|
Mechanistic insights into robust cardiac I
Topics: Arrhythmias, Cardiac; Fatty Acids, Unsaturated; Humans; KCNQ1 Potassium Channel; Long QT Syndrome; Potassium Channels; Potassium Channels, Voltage-Gated; Tyrosine | 2023 |
Block of the human ether-a-go-go-related gene (hERG) K+ channel by the antidepressant desipramine.
Topics: Animals; Antidepressive Agents, Tricyclic; Desipramine; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Inhibitory Concentration 50; Long QT Syndrome; Mutation; Oocytes; Phenylalanine; Protein Structure, Tertiary; Tyrosine; Xenopus | 2010 |
Blockade of HERG K+ channel by an antihistamine drug brompheniramine requires the channel binding within the S6 residue Y652 and F656.
Topics: Brompheniramine; Cell Line; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Histamine H1 Antagonists; Humans; Kinetics; Long QT Syndrome; Membrane Potentials; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Potassium Channel Blockers; Protein Subunits; Risk Assessment; Transfection; Tyrosine | 2008 |